Company Overview of Aldeyra Therapeutics, Inc.
Todd C. Brady M.D., Ph.D.
Chief Executive Officer, President, Director and Member of Stock Option Committee, Aldeyra Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 13 Board Members in 13 different organizations across 14 different industries.|
See Board Relationships
As of Fiscal Year 2015
131 Hartwell AvenuePhone: 781-761-4904
Lexington, Massachusetts 02421
Board Members Memberships
Chief Executive Officer, President, Director and Member of Stock Option Committee
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Duke University Medical Center
The Graduate School, Duke University
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.